Rationale design of pancreatic a-amylase inhibitor
Type 2 diabetes mellitus is a chronic metabolic disorder characterized by loss of glycaemic control. Despite the increasing incidence of type 2 diabetes mellitus, limited oral antidiabetic agents are available. Furthermore, the potency of some drugs is unjustifiable due to the level of side-effects....
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/63147 |